Saturday, September 21, 2019
Home Tags IP

Tag: IP

business model, supply chain, vloyen

U.S. Wasting $Trillions on R&D

Connecting R&D IP Instantly to Business Partners is a sea change for industry
microelectronics

Ultra-Secure, Ultra-Reliable Trusted Microelectronics Development Project Will Focus on Hardware First

The sophisticated spy-vs.-spy of cybersecurity and cyberattacks has reached the point where even the foundational hardware and materials of electronic devices needs to be...
Remake U.S. Electronics

University of Utah Engineers Join DARPA Effort to Remake U.S. Electronics

Pierre-Emmanuel Gaillardon, assistant professor of electrical and computer engineering at the University of Utah, was awarded close to $2 million over four years to...
drug discovery

Drug Discovery Must Change to Urgently Address Global Health Needs

Pharmaceutical research and development (R & D) is one of the best examples of human ingenuity, attracting vast funding and deploying the most advanced technologies....
cybersecurityvideo

A Triple-Threat Against Cyberthreats

The Department of Energy's Pacific Northwest National Laboratory has licensed three of its most unusual technologies for preventing cyberattacks to Cynash Inc., a startup...
blood clots

IU-based Drug-discovery Startup Aims to Use Nanotechnology to Digest Blood Clots...

Researchers in the Indiana University School of Medicine's Department of Emergency Medicine have launched a startup to develop nanotechnology to help people affected by blood...
depression

Drugs Found to Be More Effective Against Depression than Electric Current

A study recently published in the New England Journal of Medicine questions the efficacy of treatments for depression based on stimulating brain areas with...
Microelectronics

DARPA’s Drive to Keep the Microelectronics Revolution at Full Speed Builds...

To perpetuate the pace of innovation and progress in microelectronics technology over the past half-century, it will take an enormous village rife with innovators....
Liver Diseases

New Therapeutic Approach for Liver Diseases

HepaRegeniX GmbH, a new Biotech company developing innovative treatments for liver diseases, announced today the completion of a €9 million Series A financing. The...